← Dashboard
Aug 25, 2026 05:19 PM ET
Catalyst
FDA/Bio
J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
FDA approval marks first wAIHA treatment, a major regulatory catalyst for J&J.
What changed
Why it matters
FDA approval marks first wAIHA treatment, a major regulatory catalyst for J&J.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →